Background: Transgender patients often cannot access a provider who is knowledgeable about providing gender-affirming hormone therapy (GAHT). This study evaluated primary care provider (PCP) comfort and experience with, opinions about, and knowledge of prescribing GAHT to adults.

Methods: An anonymous Qualtrics survey was distributed to PCPs in San Diego County. Fisher's exact test assessed any association between age, years in practice, or practice setting and 1) comfort in prescribing GAHT and 2) favorable statements about learning about, providing, and benefitting from training in GAHT. T-tests determined relationship between age, years in practice, or practice type setting with number of correctly answered multiple choice knowledge-based questions out of 4.

Results: Out of 220 responses, median age was 41, 60% had practiced for ≤ 10 years, and 19% had practiced in an academic setting. Forty-two percent did not receive any education about transgender healthcare during medical training. The most commonly reported barrier to providing GAHT was lack of training (74%). PCPs age ≤ 41 (67% vs 49%, p = 0.009), PCPs practicing for ≤ 10 years (65% vs 51%, p = 0.037), and PCPs in non-academic settings (64% vs. 41%, p = 0.013) were more likely to report being comfortable with prescribing GAHT. PCPs age ≤ 41 (89% vs 62%, p < 0.001) and PCPs practicing for ≤ 10 years (86% vs 66%, p < 0.001) were more likely to show interest in learning about GAHT. PCPs age ≤ 41 (74% vs 46%, p < 0.001) and PCPs practicing for ≤ 10 years (70% vs 50%, p = 0.003) were more likely to show interest in prescribing GAHT. Knowledge scores were higher for PCPs age  ≥42 (mean 1.7 vs 1.4, p = 0.033) and PCPs working in academic centers (mean 2.0 vs 1.4, p = 0.002).

Conclusion: Younger (age ≤ 41) and early career (practicing for ≤ 10 years) PCPs reported being more comfortable with prescribing GAHT and had more favorable opinions in learning about, providing, and benefitting from training in GAHT. They are interested in providing GAHT; however, few prescribe GAHT with most reporting lack of training as a major barrier. This was evident with overall low knowledge scores regardless of age, experience, or clinical setting and underscores the need for increased educational efforts in transgender care throughout medical training.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11481314PMC
http://dx.doi.org/10.1186/s12875-024-02599-8DOI Listing

Publication Analysis

Top Keywords

prescribing gaht
12
primary care
8
care provider
8
knowledge prescribing
8
gender-affirming hormone
8
hormone therapy
8
age years
8
years practice
8
practice practice
8
pcps age ≤ 41
8

Similar Publications

Article Synopsis
  • The study investigates the social context surrounding the access and administration of gender-affirming hormonal therapy (GAHT) for trans individuals in Russia, highlighting factors that influence these practices.
  • Interviews with 20 trans individuals and 6 endocrinologists reveal that while more endocrinologists are becoming knowledgeable about GAHT, many trans people still self-medicate due to barriers like cost, age, and lack of diagnosis.
  • The research concludes that current political and medical frameworks in Russia make it challenging to adopt a more progressive model of GAHT provision, as the diagnosis of "transsexualism" remains essential for safeguarding both healthcare providers and patients.
View Article and Find Full Text PDF
Article Synopsis
  • The study highlights the growing trend of prescribing testosterone for gender affirming hormone therapy (GAHT) in Australia, primarily conducted by general practitioners (GPs), as detailed in AusPATH guidelines.
  • A cross-sectional study named PUSH! Audit was conducted in 9 GP clinics across 5 cities, comparing GAHT patients with cisgender men receiving testosterone for deficiency.
  • Results indicated that GAHT patients were generally younger, had notable health concerns like smoking and anxiety, but showed high monitoring levels and low adverse effects, making GAHT effective in general practice.
View Article and Find Full Text PDF

Background: Transgender patients often cannot access a provider who is knowledgeable about providing gender-affirming hormone therapy (GAHT). This study evaluated primary care provider (PCP) comfort and experience with, opinions about, and knowledge of prescribing GAHT to adults.

Methods: An anonymous Qualtrics survey was distributed to PCPs in San Diego County.

View Article and Find Full Text PDF

Global prevalence rates for transgender individuals vary with estimates ranging from 0.3% to 1%, translating to a potential global population of 24.3 million to 81 million.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!